The hypolipidemic peroxisome-proliferating drug, bis(carboxymethylthio)-1.10 decane, a dicarboxylic metabolite of tiadenol, is activated to an acylcoenzyme A thioester.
Bis(carboxymethylthio)-1.10 decane (BCMTD), a thiodicarboxylic acid, was shown to be a hypolipidemic peroxisome-proliferating drug as it: (a) decreased the total serum triacylglycerols and cholesterol; (b) induced hepatomegaly; (c) increased the peroxisomal beta-oxidation and catalase activity and the activities of the multiorganelle localized enzymes: palmitoyl-CoA synthetase, palmitoyl-CoA hydrolase, glycerophosphate acyltransferase; (d) decreased the carnitine palmitoyltransferase and urate oxidase activities; and (e) induced the bifunctional eonyl-CoA hydratase in peroxisomes. The present study has confirmed the effect of tiadenol administration on the activities of key enzymes involved in hepatic fatty acid metabolism in male rats. However, the hepatic pleiotropic response was more marked with the dicarboxylic acid than with its alcohol. In a separate dose-response study BCMTD was found to be a more potent inducer of peroxisomal beta-oxidation compared to tiadenol. BCMTD can be activated in vitro to its coenzyme A thioester by a dicarboxyl-CoA synthetase. In control and BCMTD-treated animals, the synthetase activity was found in all cellular fractions except the cytosolic. Whether the acyl-CoA thioesters of peroxisome-proliferating drugs may be mediators of peroxisomal proliferation should be considered.
Aarsland
A
A
Laboratory of Clinical Biochemistry, University of Bergen, Haukeland, Norway.
Berge
R K
RK
Bremer
J
J
Aarsaether
N
N
D000214:Acyl Coenzyme A / Q000378:metabolism*; D000818:Animals; D002784:Cholesterol / Q000097:blood; D003998:Dicarboxylic Acids / Q000378:metabolism* / Q000494:pharmacology; D004591:Electrophoresis, Polyacrylamide Gel; D005233:Fatty Alcohols / Q000378:metabolism*; D000960:Hypolipidemic Agents / Q000378:metabolism*; D008099:Liver / Q000032:analysis / Q000201:enzymology; D008297:Male; D008830:Microbodies / Q000187:drug effects*; D010084:Oxidation-Reduction; D051381:Rats; D011919:Rats, Inbred Strains; D013440:Sulfides / Q000378:metabolism* / Q000494:pharmacology; D014280:Triglycerides / Q000097:blood
D000214:Acyl Coenzyme A; D003998:Dicarboxylic Acids; D005233:Fatty Alcohols; D000960:Hypolipidemic Agents; D013440:Sulfides; D014280:Triglycerides; C004568:tiadenol; C062079:1,10-bis(carboxymethylthiodecane); D002784:Cholesterol